CTLA4 and neoplasm: 2.6. IntraTumor Gene Expression in First-Line Anti-PD-1 Antibody-Resistant CT-26 Tumor-Bearing Mice after Second-Line Therapy with Chidamide-k30 Combined with Cabozantinib/Regorafenib Plus Anti-CTLA-4 Antibody